S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom

Cara Therapeutics (CARA) Insider Trading & Ownership

$0.73
+0.02 (+2.81%)
(As of 04/17/2024 ET)

Cara Therapeutics (NASDAQ:CARA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.20%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
5
Amount Of
Insider Selling
(Last 12 Months)
$85,004.00
Get CARA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Cara Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

CARA Insider Buying and Selling by Quarter

Cara Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/5/2024Joana GoncalvesInsiderSell2,753$0.83$2,284.99  
2/8/2024Christopher PosnerCEOSell35,575$0.53$18,854.75  
2/8/2024Ryan D MaynardCFOSell5,488$0.53$2,908.64  
2/8/2024Scott TerrillionInsiderSell7,770$0.53$4,118.10  
2/1/2024Christopher PosnerCEOSell4,981$0.55$2,739.55  
11/2/2023Christopher PosnerCEOSell3,796$1.22$4,631.12  
8/3/2023Christopher PosnerCEOSell4,307$3.07$13,222.49  
6/23/2023Frederique Ph.D. MenzaghiSVPSell2,993$3.51$10,505.43  
6/23/2023Scott TerrillionInsiderSell2,483$3.51$8,715.33  
5/5/2023Christopher PosnerCEOSell3,869$4.40$17,023.60  
(Data available from 1/1/2013 forward)

CARA Insider Trading Activity - Frequently Asked Questions

Who is on Cara Therapeutics's Insider Roster?

The list of insiders at Cara Therapeutics includes Christopher Posner, Derek T Chalmers, Frederique Ph.D. Menzaghi, Jeffrey L Ives, Joana Goncalves, Martin Vogelbaum, Ryan D Maynard, Scott Terrillion, and Thomas Charles Reilly. Learn more on insiders at CARA.

What percentage of Cara Therapeutics stock is owned by insiders?

4.20% of Cara Therapeutics stock is owned by insiders. Learn more on CARA's insider holdings.

Which Cara Therapeutics insiders have been selling company stock?

The following insiders have sold CARA shares in the last 24 months: Christopher Posner ($266,976.41), Frederique Ph.D. Menzaghi ($63,437.08), Jeffrey L Ives ($32,580.00), Joana Goncalves ($60,489.48), Martin Vogelbaum ($111,024.00), Ryan D Maynard ($2,908.64), and Scott Terrillion ($25,015.14).

How much insider selling is happening at Cara Therapeutics?

Insiders have sold a total of 121,053 Cara Therapeutics shares in the last 24 months for a total of $562,430.75 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:CARA) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners